SYK vs VSTM · P/E 35, rev $6.59B vs rev $58.7M
Stryker Corporation (SYK) versus Verastem Inc (VSTM) — a side-by-side from cached financials, not a winner call.
Stryker Corporation (SYK) is a medical devices company listed on NYSE.
Verastem Inc (VSTM) is a biotechnology company listed on US.
Latest reported SYK revenue for 2026-06-30 was $6.59B. Net income was $1.28B. Revenue was up 9.5% from 2026-03-31 to 2026-06-30. SYK currently screens at market cap $115.45B and trailing P/E 34.9.
Latest reported VSTM revenue for 2026-06-30 was $58.7M. Net income was -$71.3M. VSTM currently screens at market cap $264.3M.
SYK currently screens at market cap $115.45B and trailing P/E 34.9. VSTM currently screens at market cap $264.3M.
Not investment advice. Open the SYK and VSTM stock pages for the full models.
Not investment advice.